肝脏 ›› 2019, Vol. 24 ›› Issue (12): 1387-1392.

• 论著 • 上一篇    下一篇

5-羟色胺通过上调2B受体抑制放线菌素D诱导肝细胞凋亡初步实验研究

马丽霞, 高玉娟, 刘晓慧, 张晶   

  1. 100069 首都医科大学附属北京佑安医院丙型肝炎与中毒性肝病科(马丽霞,刘晓慧,张晶);南京大学附属南京鼓楼医院呼吸与危重症医学科(高玉娟)
  • 收稿日期:2019-09-18 发布日期:2020-03-28
  • 通讯作者: 张晶,Email:drzhangjing@163.com

5-HT inhibits actinomycin D induced hepatocyte apoptosis by upregulating 2B receptor

MA Li-xia, GAO Yu-juan, LIU Xiao-hui, ZHANG Jing   

  1. Department of Hepatitis C and Toxic Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China
  • Received:2019-09-18 Published:2020-03-28
  • Contact: ZHANG Jing, Email: drzhangjing@163.com

摘要: 目的 探讨5-羟色胺(5-HT)在肝细胞凋亡中的作用及机制。方法 以不同浓度梯度放线菌素D(AcD)分别诱导HepG2和7702细胞凋亡,采用AnnexinV-FITC/PI流式细胞术和TUNEL方法检测细胞凋亡,MTT法检测细胞存活率。AcD预处理HepG2细胞后分别加入5-HT、5-HT 2A受体激动剂DOI、5-HT 2B受体激动剂M110、5-HT 2B受体拮抗剂SB204+5-HT,AnnexinV-FITC/PI流式细胞术和MTT法分别检测细胞凋亡率和存活率,蛋白质印迹法检测蛋白水解酶3(caspase3)、丝氨酸/苏氨酸蛋白激酶(AKT)及磷酸化丝氨酸/苏氨酸蛋白激酶(p-AKT)的表达。结果 AcD以浓度依赖性方式分别诱导HepG2细胞和7702细胞的凋亡,50 ng/mL AcD处理两种细胞凋亡率均高于无血清对照组(HePG2细胞t=1.71,7702细胞t=1.98,均P<0.05),与单用AcD组相比,5-HT使HepG2细胞凋亡率从31.96%±2.13%降至10.24%±2.59%(t=1.62,P<0.05),5-HT 2B受体激动剂使其降至8.41%±0.96%(t=1.75,P<0.05),反之,5-HT 2B受体拮抗剂能拮抗5-HT的抗凋亡作用,其凋亡率为25.92%±1.33%(t=1.45,P>0.05)。5-HT及5-HT 2B受体激动剂均能够减少caspase3活化,增加AKT的磷酸化,使细胞凋亡减少。结论 5-HT通过上调5-HT 2B受体促进AKT磷酸化,从而抑制AcD诱导的肝细胞凋亡。

关键词: 放线菌素D, 5-HT, 肝细胞凋亡, AKT磷酸化, 5-HT 2B受体

Abstract: Objective To investigate the role and mechanism of 5-hydroxytryptamine (5-HT) in hepatocyte apoptosis, and to provide evidence for the application of 5-HT in liver diseases.Methods Apoptosis of HepG2 and 7702 cells was induced by different concentrations of actinomycin-D (AcD). After AcD pretreatment of HepG2 cells, 5-HT, 5-HT 2A receptor agonist DOI, 5-HT 2B receptor agonist M110, and 5-HT 2B receptor antagonist SB204 with 5-HT were added respectively. Then, apoptotic rates and survival rates were detected by Annexin V-FITC/PI flow cytometry and MTT assay, expressions of aspartate specific protease 3 (caspase-3), serine/threonine protein kinase (AKT) and phosphorylated serine/threonine protein kinase (p-AKT) were detected by Western blot method. Results AcD induced apoptosis of HepG2 cells and 7702 cells in a concentration-dependent manner. The apoptotic rates of cells treated with 50 ng/ml AcD were higher than those of serum-free control group (HepG2 cells t=1.71, 7702 cells t=1.98, P<0.05). Compared with the AcD group, 5-HT decreased the apoptosis rate of HepG2 cells from 31.96% ± 2.13% to 10.24% ± 2.59% (t=1.62, P<0.05), and the 5-HT 2B receptor agonist decreased the apoptosis rate to 8.41% ± 0.96% (t=1.75, P<0.05). On the contrary, the 5-HT 2B receptor antagonist antagonize the anti-apoptotic effect of 5-HT, making the apoptotic rate 25.92% ± 1.33% (t=1.45, P>0.05). Both 5-HT and 5-HT 2B receptor agonists reduced the activation of caspase3, increased the phosphorylation of AKT, and decreased the apoptosis.Conclusion 5-HT promotes AKT phosphorylation by up-regulating 5-HT 2B receptor, thereby inhibiting AcD-induced hepatocyte apoptosis.

Key words: Actinomycin-D, 5-hydroxtryptamine, Hepatocyte apoptosis, AKT phosphorylation, 5-HT 2B receptor